EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 1b

Ensembl ID : ENSOSIG00000006117
Gene Symbol: ATP1B1B
1 Cross references
220 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSOSIG00000002171
Gene Symbol: ATP1B2
1 Cross references
200 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSOSIG00000022327
Gene Symbol: ATP1B2B
1 Cross references
203 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3a

Ensembl ID : ENSOSIG00000006830
Gene Symbol: ATP1B3A
1 Cross references
236 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSOSIG00000017254
Gene Symbol: ATP1B3B
1 Cross references
232 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSOSIG00000012736
Gene Symbol: AXL
1 Cross references
187 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOSIG00000020811
Gene Symbol: BCL2
1 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOSIG00000015055
Gene Symbol: BCL2L1
1 Cross references
226 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOSIG00000009295
Gene Symbol: BCL2L1
1 Cross references
216 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSOSIG00000010360
Gene Symbol: BCL2L10
1 Cross references
128 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSOSIG00000006748
Gene Symbol: BCR
1 Cross references
205 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSOSIG00000008752
Gene Symbol: BTK
1 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).